User profiles for Riccardo Magistroni

Riccardo Magistroni

Assistant Professor
Verified email at unimore.it
Cited by 5622

Unified criteria for ultrasonographic diagnosis of ADPKD

…, A Dupuis, AD Paterson, R Magistroni… - Journal of the …, 2009 - journals.lww.com
Individuals who are at risk for autosomal dominant polycystic kidney disease are often screened
by ultrasound using diagnostic criteria derived from individuals with mutations in PKD1. …

Genome-wide association study identifies susceptibility loci for IgA nephropathy

…, I Tikhonova, I Beerman, S Savoldi, R Magistroni… - Nature …, 2011 - nature.com
We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney
failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with …

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

…, R Coppo, M Salvadori, P Ravani, R Magistroni… - Nature …, 2014 - nature.com
We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most
common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of …

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

…, S Granata, G Zaza, F Londrino, R Magistroni… - Nature …, 2023 - nature.com
IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular
deposition of IgA. Here we performed a genome-wide association study of 10,146 kidney-biopsy-…

[HTML][HTML] New developments in the genetics, pathogenesis, and therapy of IgA nephropathy

R Magistroni, VD D'Agati, GB Appel, K Kiryluk - Kidney international, 2015 - Elsevier
Recent years have brought notable progress in the field of IgA nephropathy. Here, we
highlight important new directions and latest developments, including successful discovery of …

[HTML][HTML] The MEST score provides earlier risk prediction in lgA nephropathy

…, A Wiecek, M Ots-Rosenberg, R Magistroni… - Kidney international, 2016 - Elsevier
The Oxford Classification of IgA nephropathy (IgAN) includes the following four histologic
components: mesangial (M) and endocapillary (E) hypercellularity, segmental sclerosis (S) and …

Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial

…, C Marcantoni, P Passerini, R Magistroni… - Journal of the …, 2021 - journals.lww.com
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a more …

[HTML][HTML] Hypokalemia in patients with COVID-19

…, R Perrone, G Mori, E Ascione, R Magistroni… - Clinical and …, 2021 - Springer
Background Patients with COVID-19 experience multiple clinical conditions that may cause
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …

Covid‐19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine

…, F Facchini, F Damiano, R Magistroni… - American Journal of …, 2020 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19) pneumonia has been poorly reported in solid organ
transplanted patients; prognosis is uncertain and best management unclear. We describe …

Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy

…, G Candiano, G Moroni, R Magistroni… - Clinical Journal of the …, 2012 - journals.lww.com
Results IgG 4 was the most common isotype for all antibodies; IgG 1 and IgG 3 were nearly
negligible. IgG 4 levels were positive in a significant proportion of MN patients (AR, 34%; …